Search

Search Constraints

You searched for: Author/Creator Yu, Brian

Search Results

1. Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection. Issue 11 (November 2018)

6. Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia. (24th March 2020)

8. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. (12th January 2022)

10. Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2. Issue 6 (27th October 2021)